• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高亲和力胰岛素样生长因子结合蛋白与水貂肺上皮细胞中V型转化生长因子-β受体的相互作用。

Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells.

作者信息

Leal S M, Huang S S, Huang J S

机构信息

Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri 63104, USA.

出版信息

J Biol Chem. 1999 Mar 5;274(10):6711-7. doi: 10.1074/jbc.274.10.6711.

DOI:10.1074/jbc.274.10.6711
PMID:10037769
Abstract

High affinity insulin-like growth factor-binding proteins (IGFBP-1 to -6) are a family of structurally homologous proteins that induce cellular responses by insulin-like growth factor (IGF)-dependent and -independent mechanisms. The IGFBP-3 receptor, which mediates the IGF-independent growth inhibitory response, has recently been identified as the type V transforming growth factor-beta receptor (TbetaR-V) (Leal, S. M., Liu, Q. L., Huang, S. S., and Huang, J. S. (1997) J. Biol. Chem. 272, 20572-20576). To characterize the interactions of high affinity IGFBPs with TbetaR-V, mink lung epithelial cells (Mv1Lu cells) were incubated with 125I-labeled recombinant human IGFBPs (125I-IGFBP-1 to -6) in the presence of the cross-linking agent disuccinimidyl suberate and analyzed by 5% SDS-polyacrylamide gel electrophoresis and autoradiography. 125I-IGFBP-3, -4, and -5 but not 125I-IGFBP-1, -2, and -6 bound to TbetaR-V as demonstrated by the detection of the approximately 400-kDa 125I-IGFBP.TbetaR-V cross-linked complex in the cell lysates and immunoprecipitates. The analyses of 125I-labeled ligand binding competition and DNA synthesis inhibition revealed that IGFBP-3 was a more potent ligand for TbetaR-V than IGFBP-4 or -5. Most of the high affinity 125I-IGFBPs formed dimers at the cell surface. The cell-surface dimer of 125I-IGFBP-3 preferentially bound to and was cross-linked to TbetaR-V in the presence of disuccinimidyl suberate. IGFBP-3 did not stimulate the cellular phosphorylation of Smad2 and Smad3, key transducers of the transforming growth factor-beta type I/type II receptor (TbetaR-I.TbetaR-II) heterocomplex-mediated signaling. These results suggest that IGFBP-3, -4, and -5 are specific ligands for TbetaR-V, which mediates the growth inhibitory response through a signaling pathway(s) distinct from that mediated by the TbetaR-I and TbetaR-II heterocomplex.

摘要

高亲和力胰岛素样生长因子结合蛋白(IGFBP - 1至 - 6)是一类结构同源的蛋白质家族,它们通过胰岛素样生长因子(IGF)依赖和非依赖机制诱导细胞反应。介导IGF非依赖生长抑制反应的IGFBP - 3受体,最近被鉴定为V型转化生长因子 - β受体(TbetaR - V)(Leal, S. M., Liu, Q. L., Huang, S. S., and Huang, J. S. (1997) J. Biol. Chem. 272, 20572 - 20576)。为了表征高亲和力IGFBPs与TbetaR - V的相互作用,将貂肺上皮细胞(Mv1Lu细胞)与125I标记的重组人IGFBPs(125I - IGFBP - 1至 - 6)在交联剂辛二酸二琥珀酰亚胺酯存在下孵育,并通过5% SDS - 聚丙烯酰胺凝胶电泳和放射自显影进行分析。如在细胞裂解物和免疫沉淀中检测到约400 kDa的125I - IGFBP.TbetaR - V交联复合物所示,125I - IGFBP - 3、 - 4和 - 5与TbetaR - V结合,而125I - IGFBP - 1、 - 2和 - 6不结合。125I标记的配体结合竞争和DNA合成抑制分析表明,IGFBP - 3是比IGFBP - 4或 - 5更强效的TbetaR - V配体。大多数高亲和力的125I - IGFBPs在细胞表面形成二聚体。在辛二酸二琥珀酰亚胺酯存在下,125I - IGFBP - 3的细胞表面二聚体优先结合并与TbetaR - V交联。IGFBP - 3不刺激Smad2和Smad3的细胞磷酸化,Smad2和Smad3是转化生长因子 - β I型/II型受体(TbetaR - I.TbetaR - II)异源复合物介导信号传导的关键转导因子。这些结果表明,IGFBP - 3、 - 4和 - 5是TbetaR - V的特异性配体,TbetaR - V通过与TbetaR - I和TbetaR - II异源复合物介导的信号传导途径不同的信号传导途径介导生长抑制反应。

相似文献

1
Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells.高亲和力胰岛素样生长因子结合蛋白与水貂肺上皮细胞中V型转化生长因子-β受体的相互作用。
J Biol Chem. 1999 Mar 5;274(10):6711-7. doi: 10.1074/jbc.274.10.6711.
2
Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells.鉴定胰岛素受体底物蛋白为转化生长因子β受体V/低密度脂蛋白受体相关蛋白1介导的上皮细胞和髓样细胞生长抑制信号级联反应的关键分子。
FASEB J. 2004 Nov;18(14):1719-21. doi: 10.1096/fj.04-1872fje. Epub 2004 Sep 15.
3
Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1.IGFBP - 3和TGF - β1对细胞生长的抑制作用需要低密度脂蛋白受体相关蛋白1(LRP - 1)。
FASEB J. 2003 Nov;17(14):2068-81. doi: 10.1096/fj.03-0256com.
4
The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor.V型转化生长因子β受体是假定的胰岛素样生长因子结合蛋白3受体。
J Biol Chem. 1997 Aug 15;272(33):20572-6. doi: 10.1074/jbc.272.33.20572.
5
The mannose 6-phosphate/insulin-like growth factor-II receptor is a substrate of type V transforming growth factor-beta receptor.甘露糖6-磷酸/胰岛素样生长因子-II受体是V型转化生长因子-β受体的底物。
J Biol Chem. 1999 Jul 9;274(28):20002-10. doi: 10.1074/jbc.274.28.20002.
6
Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.胰岛素样生长因子结合蛋白-2介导转化生长因子-β对水貂肺上皮细胞DNA合成的抑制作用。
J Cell Physiol. 2002 Jan;190(1):63-73. doi: 10.1002/jcp.10034.
7
Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin-like growth factor binding protein-3.胰岛素样生长因子结合蛋白-3对增殖的貂肺上皮细胞中DNA合成抑制作用的表征
J Cell Biochem. 2000 Mar;77(2):288-97. doi: 10.1002/(sici)1097-4644(20000501)77:2<288::aid-jcb11>3.0.co;2-j.
8
TGF-beta control of cell proliferation.转化生长因子-β对细胞增殖的调控
J Cell Biochem. 2005 Oct 15;96(3):447-62. doi: 10.1002/jcb.20558.
9
Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells.V型转化生长因子β受体在转化生长因子β诱导的水貂肺上皮细胞生长抑制中的作用
J Biol Chem. 1997 Jul 25;272(30):18891-5. doi: 10.1074/jbc.272.30.18891.
10
Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.细胞硫酸乙酰肝素对上皮细胞中转化生长因子-β1(TGF-β1)的反应性具有负调节作用。
J Biol Chem. 2006 Apr 28;281(17):11506-14. doi: 10.1074/jbc.M512821200. Epub 2006 Feb 21.

引用本文的文献

1
Role of IGFBP-3 in Human Diseases Relying on Different Cell Signaling Pathways.胰岛素样生长因子结合蛋白-3在依赖不同细胞信号通路的人类疾病中的作用。
Adv Biomed Res. 2025 Feb 28;14:15. doi: 10.4103/abr.abr_23_23. eCollection 2025.
2
Signaling Pathways of the Insulin-like Growth Factor Binding Proteins.胰岛素样生长因子结合蛋白的信号通路。
Endocr Rev. 2023 Sep 15;44(5):753-778. doi: 10.1210/endrev/bnad008.
3
IGFBP-3 and TGF-β inhibit growth in epithelial cells by stimulating type V TGF-β receptor (TβR-V)-mediated tumor suppressor signaling.
胰岛素样生长因子结合蛋白3(IGFBP-3)和转化生长因子-β(TGF-β)通过刺激V型转化生长因子-β受体(TβR-V)介导的肿瘤抑制信号来抑制上皮细胞生长。
FASEB Bioadv. 2021 Jun 16;3(9):709-729. doi: 10.1096/fba.2021-00016. eCollection 2021 Sep.
4
Insulin-like growth factors: Ligands, binding proteins, and receptors.胰岛素样生长因子:配体、结合蛋白和受体。
Mol Metab. 2021 Oct;52:101245. doi: 10.1016/j.molmet.2021.101245. Epub 2021 May 4.
5
IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer.IGFBP-3/IGFBP-3 受体系统作为肿瘤的抗肿瘤和抗转移信号。
Cells. 2020 May 20;9(5):1261. doi: 10.3390/cells9051261.
6
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment.了解癌症中靶向IGF轴的关键:生物标志物评估
Front Oncol. 2015 Jul 8;5:142. doi: 10.3389/fonc.2015.00142. eCollection 2015.
7
Activation of various downstream signaling molecules by IGFBP-3.IGFBP - 3对各种下游信号分子的激活作用。
J Cancer Ther. 2014 Aug 1;5(9):830-835. doi: 10.4236/jct.2014.59091.
8
A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.一种解释特定细胞通讯与细胞协调的模型:耦合细胞与交互式耦合分子的假说
Theor Biol Med Model. 2014 Sep 14;11:40. doi: 10.1186/1742-4682-11-40.
9
IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival.胰岛素样生长因子结合蛋白7诱导急性髓系白血病细胞凋亡,并与化疗协同抑制白血病细胞存活。
Cell Death Dis. 2014 Jun 26;5(6):e1300. doi: 10.1038/cddis.2014.268.
10
IGF binding proteins in cancer: mechanistic and clinical insights.癌症中的 IGF 结合蛋白:机制与临床见解。
Nat Rev Cancer. 2014 May;14(5):329-41. doi: 10.1038/nrc3720. Epub 2014 Apr 10.